Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1907 1
1911 1
1914 4
1916 2
1917 1
1918 2
1919 2
1921 3
1923 1
1925 1
1926 1
1927 1
1928 2
1930 2
1931 1
1932 2
1944 1
1945 1
1946 5
1947 7
1948 10
1949 6
1950 15
1951 19
1952 27
1953 24
1954 21
1955 24
1956 22
1957 27
1958 24
1959 28
1960 31
1961 30
1962 28
1963 33
1964 46
1965 49
1966 39
1967 53
1968 63
1969 60
1970 52
1971 48
1972 59
1973 53
1974 47
1975 53
1976 50
1977 59
1978 44
1979 61
1980 51
1981 68
1982 66
1983 71
1984 93
1985 77
1986 88
1987 85
1988 109
1989 84
1990 77
1991 71
1992 62
1993 118
1994 87
1995 106
1996 84
1997 75
1998 82
1999 83
2000 104
2001 88
2002 104
2003 103
2004 96
2005 127
2006 126
2007 140
2008 169
2009 135
2010 142
2011 175
2012 189
2013 201
2014 208
2015 232
2016 255
2017 251
2018 262
2019 274
2020 286
2021 304
2022 298
2023 294
2024 115

Text availability

Article attribute

Article type

Publication date

Search Results

7,030 results

Results by year

Filters applied: . Clear all
Page 1
Strengthening brittle bones.
Shoemaker AH. Shoemaker AH. Sci Transl Med. 2017 Jun 28;9(396):eaan6730. doi: 10.1126/scitranslmed.aan6730. Sci Transl Med. 2017. PMID: 28659442
Decreased WNT1 signaling weakens bones but is partially reversed by blocking the WNT1 inhibitory regulator sclerostin....
Decreased WNT1 signaling weakens bones but is partially reversed by blocking the WNT1 inhibitory regulator sclerostin....
Brittle bones, deformities & deafness.
Khot R, Sonawane B. Khot R, et al. Indian J Med Res. 2020 Nov;152(Suppl 1):S120. doi: 10.4103/ijmr.IJMR_2196_19. Indian J Med Res. 2020. PMID: 35345159 Free PMC article. No abstract available.
Blue eyes, brittle bones.
Morton A. Morton A. Aust J Gen Pract. 2021 Jun;50(6):377-378. doi: 10.31128/AJGP-06-20-5493. Aust J Gen Pract. 2021. PMID: 34059841 Free article. No abstract available.
Current Overview of Osteogenesis Imperfecta.
Deguchi M, Tsuji S, Katsura D, Kasahara K, Kimura F, Murakami T. Deguchi M, et al. Medicina (Kaunas). 2021 May 10;57(5):464. doi: 10.3390/medicina57050464. Medicina (Kaunas). 2021. PMID: 34068551 Free PMC article. Review.
Osteogenesis imperfecta (OI), or brittle bone disease, is a heterogeneous disorder characterised by bone fragility, multiple fractures, bone deformity, and short stature. ...
Osteogenesis imperfecta (OI), or brittle bone disease, is a heterogeneous disorder characterised by bone fragility, mul …
Osteogenesis imperfecta: advancements in genetics and treatment.
Rossi V, Lee B, Marom R. Rossi V, et al. Curr Opin Pediatr. 2019 Dec;31(6):708-715. doi: 10.1097/MOP.0000000000000813. Curr Opin Pediatr. 2019. PMID: 31693577 Free PMC article. Review.
The standard of care in pediatric patients is bisphosphonates therapy. Ongoing preclinical studies in osteogenesis imperfecta mouse models and clinical studies in individuals with osteogenesis imperfecta have been instrumental in the development of new …
The standard of care in pediatric patients is bisphosphonates therapy. Ongoing preclinical studies in osteogenesis imperfecta …
Syndromes with congenital brittle bones.
Plotkin H. Plotkin H. BMC Pediatr. 2004 Aug 31;4:16. doi: 10.1186/1471-2431-4-16. BMC Pediatr. 2004. PMID: 15339338 Free PMC article. Review.
Some of these syndromes can actually be considered congenital forms of brittle bones resembling OI (SROI). DISCUSSION: A review of different syndromes with congenital brittle bones published in the literature is presented. ...A definition for OI is pro …
Some of these syndromes can actually be considered congenital forms of brittle bones resembling OI (SROI). DISCUSSION: A revie …
Osteogenesis imperfecta.
Marini JC, Forlino A, Bächinger HP, Bishop NJ, Byers PH, Paepe A, Fassier F, Fratzl-Zelman N, Kozloff KM, Krakow D, Montpetit K, Semler O. Marini JC, et al. Nat Rev Dis Primers. 2017 Aug 18;3:17052. doi: 10.1038/nrdp.2017.52. Nat Rev Dis Primers. 2017. PMID: 28820180 Review.
Skeletal deformity and bone fragility are the hallmarks of the brittle bone dysplasia osteogenesis imperfecta. The diagnosis of osteogenesis imperfecta usually depends on family history and clinical presentation characterized by a fracture (or f …
Skeletal deformity and bone fragility are the hallmarks of the brittle bone dysplasia osteogenesis imperfecta. The diag …
Osteogenesis imperfecta: an update on clinical features and therapies.
Marom R, Rabenhorst BM, Morello R. Marom R, et al. Eur J Endocrinol. 2020 Oct;183(4):R95-R106. doi: 10.1530/EJE-20-0299. Eur J Endocrinol. 2020. PMID: 32621590 Free PMC article. Review.
Osteogenesis imperfecta (OI) is an inherited skeletal dysplasia characterized by bone fragility and skeletal deformities. ...
Osteogenesis imperfecta (OI) is an inherited skeletal dysplasia characterized by bone fragility and skeletal deformities. ...
Brittle bones--fragile molecules: disorders of collagen gene structure and expression.
Byers PH. Byers PH. Trends Genet. 1990 Sep;6(9):293-300. doi: 10.1016/0168-9525(90)90235-x. Trends Genet. 1990. PMID: 2238087 Review.
Mutations in the genes that encode the chains of type I collagen, the major structural protein in most tissues, usually produce brittle bones. The consequences of even apparently minor mutations--single base substitutions--can range from lethal to mild, and the phen …
Mutations in the genes that encode the chains of type I collagen, the major structural protein in most tissues, usually produce brittle …
Osteogenesis Imperfecta: Current and Prospective Therapies.
Botor M, Fus-Kujawa A, Uroczynska M, Stepien KL, Galicka A, Gawron K, Sieron AL. Botor M, et al. Biomolecules. 2021 Oct 10;11(10):1493. doi: 10.3390/biom11101493. Biomolecules. 2021. PMID: 34680126 Free PMC article. Review.
Osteogenesis Imperfecta (OI) is a group of connective tissue disorders with a broad range of phenotypes characterized primarily by bone fragility. ...
Osteogenesis Imperfecta (OI) is a group of connective tissue disorders with a broad range of phenotypes characterized primaril …
7,030 results